Buscar
17/07/2026
Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression (Vol 21, e0329751, 2026)
Acosta, L, Soldevila, N, Torner, N, Avellon, A, Hernando, V, Borras, E, Martínez, A, Pericas, C, Rius, C, Godoy, P, Dominguez, A. Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression (Vol 21, e0329751, 2026). PLoS One. 2026; 21(7)DOI:10.1371/journal.pone.0354253. PMID:. IF:2.600(Q2/4D).
16/07/2026
Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort
Lozano-Rivas, N, Rúa-Figueroa, I, Freire-González, M, Turrión, A, Castellvi, I, Ajo, JB, Calvo-Alén, J, Ortego-Centeno, N, Díaz-Encarnación, M, Pego-Reigosa, JM, Ding, B, Galvez-Fernandez, M, Bahamontes-Rosa, N, Cervera, R. Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort. Lupus Science & Medicine. 2026; 13(2)DOI:10.1136/lupus-2026-002054. PMID:42463277. IF:3.500(Q2/3D).
15/07/2026
International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and Portugal
Tapia, JC, Gavira, J, Matthews, D, Santoni, M, Young, M, Blondel, L, Flippot, R, Frazer, R, Anguera, G, Maroto, P. International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and Portugal. INTERNATIONAL JOURNAL OF CANCER. 2026; 159(2)DOI:10.1002/ijc.70379. PMID:41653082. IF:4.700(Q1/3D).
15/07/2026
A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice
dos Santos, BG, Brisnovali, NF, Haney, C, Coven, M, Sebzevari, HL, Gaebel, L, Zhang, XB, Sun, JAT, Canfrán-Duque, A, Rotllan, N, Nasiri, A, Kahn, M, McAlpine, CS, Shulman, GI, Goedeke, L. A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice. Science Translational Medicine. 2026; 18(858)DOI:10.1126/scitranslmed.adv1815. PMID:42455898. IF:14.600(Q1/1D).
14/07/2026
Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old
Ceriello, C, Torres, OH, Rubio-Guerra, S, García-Castro, J, Selma-Gonzalez, J, Sala, I, Sánchez-Saudinós, MB, Videla, L, Vera-Campuzano, E, Arranz, J, Rodríguez-Baz, I, Maure-Blesa, L, Dols-Icardo, O, Valldeneu, S, Barroeta, I, Santos-Santos, M, Carmona-Iragui, M, Vaqué-Alcázar, L, Alvarez-Sanchez, E, Lorente, O, Carreras, M, Bejanin, A, Belbin, O, Lleó, A, Fortea, J, Alcolea, D, Illán-Gala, I. Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old. NEUROLOGY. 2026; 107(1)DOI:10.1212/WNL.0000000000218180. PMID:42308436. IF:8.500(Q1/1D).
14/07/2026
Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Allen, JA, Eftimov, F, Querol, L, Sommer, C, Dimachkie, MM, Fix, C, Gable, K, Gorson, KC, Harbo, T, Karam, C, Koike, H, Kuitwaard, K, Lunn, MP, Nobile-Orazio, E, Pasnoor, M, Rajabally, YA, Peric, S, Reisin, R, Butler, L. Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy. NEUROLOGY. 2026; 107(1)DOI:10.1212/WNL.0000000000218159. PMID:42302218. IF:8.500(Q1/1D).